Civic Intelligence

Associated Scientists to Help Minimize Allergies

EIN 23-7219813 • 501(c)3 • Seattle, WA

Profile

To investigate new treatments in allergy, asthma, and immunology. The corporation is organized as a not-for-profit, exclusively for scientific, literary, and educational purposes. Clinical investigations are supported by the research and development divisions of major pharmaceutical companies and the national heart, lung, and blood institute of the national institutes of health.

9725 3rd Avenue NESeattle, WA 98115-2024

www.asthmainc.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2025

Liabilities / Revenue

99th percentile

15.26x

Higher debt load relative to revenue than 99% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Net Margin

5th percentile

-270%

Higher net margin than 5% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2025

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

9th percentile

-100%

Faster asset growth than 9% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Revenue Growth

6th percentile

-92%

Faster revenue growth than 6% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2024 to 2025

Assets

Down

$0

Down $185,799 (-100%) from 2024

Liabilities

Up

$273,922

Up $19,241 (+7.6%) from 2024

Net Assets

Down

-$273,922

Down $205,040 (-298%) from 2024

Revenue

Down

$17,955

Down $195,570 (-92%) from 2024

Expenses

Down

$66,436

Down $318,898 (-83%) from 2024

Net Income

Up

-$48,481

Up $123,328 (+72%) from 2024

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$1.5M$1.0M$500K$0-$500KAssets 2010: $783,927Liabilities 2010: $76,569Net Assets 2010: $707,3582010Assets 2011: $717,996Liabilities 2011: $63,416Net Assets 2011: $654,5802011Assets 2013: $484,517Liabilities 2013: $102,060Net Assets 2013: $382,4572013Assets 2014: $499,879Liabilities 2014: $294,462Net Assets 2014: $205,4172014Assets 2015: $709,910Liabilities 2015: $430,024Net Assets 2015: $279,8862015Assets 2016: $631,321Liabilities 2016: $270,747Net Assets 2016: $360,5742016Assets 2017: $755,519Liabilities 2017: $221,152Net Assets 2017: $534,3672017Assets 2018: $714,426Liabilities 2018: $146,359Net Assets 2018: $568,0672018Assets 2019: $571,754Liabilities 2019: $91,126Net Assets 2019: $480,6282019Assets 2020: $1,029,280Liabilities 2020: $365,193Net Assets 2020: $664,0872020Assets 2021: $774,027Liabilities 2021: $59,316Net Assets 2021: $714,7112021Assets 2022: $605,334Liabilities 2022: $145,759Net Assets 2022: $459,5752022Assets 2024: $185,799Liabilities 2024: $254,681Net Assets 2024: -$68,8822024Assets 2025: $0Liabilities 2025: $273,922Net Assets 2025: -$273,9222025

Highlighted filing

2025

Assets$0
Liabilities$273,922
Net Assets-$273,922

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$2.0M$1.5M$1.0M$500K$0-$500KExpenses 2010: $1,112,4962010Expenses 2011: $1,114,0092011Revenue 2013: $651,587Expenses 2013: $951,554Net Income 2013: -$299,9672013Revenue 2014: $824,610Expenses 2014: $1,001,650Net Income 2014: -$177,0402014Revenue 2015: $1,121,685Expenses 2015: $1,047,216Net Income 2015: $74,4692015Revenue 2016: $1,455,634Expenses 2016: $1,374,946Net Income 2016: $80,6882016Revenue 2017: $1,653,813Expenses 2017: $1,480,020Net Income 2017: $173,7932017Revenue 2018: $1,514,765Expenses 2018: $1,481,065Net Income 2018: $33,7002018Revenue 2019: $1,134,349Expenses 2019: $1,221,788Net Income 2019: -$87,4392019Revenue 2020: $1,438,574Expenses 2020: $1,255,115Net Income 2020: $183,4592020Revenue 2021: $1,238,235Expenses 2021: $1,187,611Net Income 2021: $50,6242021Revenue 2022: $1,011,590Expenses 2022: $1,266,726Net Income 2022: -$255,1362022Revenue 2024: $213,525Expenses 2024: $385,334Net Income 2024: -$171,8092024Revenue 2025: $17,955Expenses 2025: $66,436Net Income 2025: -$48,4812025

Highlighted filing

2025

Revenue$17,955
Expenses$66,436
Net Income-$48,481

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.00$0.27$0.27$0.02$0.07$0.05
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.19$0.25$0.07$0.21$0.39$0.17
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.61$0.15$0.46$1.01$1.27$0.26
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.77$0.06$0.71$1.24$1.19$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.03$0.37$0.66$1.44$1.26$0.18
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.57$0.09$0.48$1.13$1.22$0.09
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.71$0.15$0.57$1.51$1.48$0.03
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.76$0.22$0.53$1.65$1.48$0.17
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.63$0.27$0.36$1.46$1.37$0.08
2015Detailed filing. Detailed filing data is available for this year.$0.71$0.43$0.28$1.12$1.05$0.07
2014Detailed filing. Detailed filing data is available for this year.$0.50$0.29$0.21$0.82$1.00$0.18
2013Detailed filing. Detailed filing data is available for this year.$0.48$0.10$0.38$0.65$0.95$0.30
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.72$0.06$0.65$1.11
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.78$0.08$0.71$1.11
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2025 to Jun 30, 2025
Signed
Jan 8, 2026
Return Version
2025v4.0
Gross Receipts
$17,955
Mission and Program Overview

Mission

To investigate new treatments in allergy, asthma, and immunology. The corporation is organized as a not-for-profit, exclusively for scientific, literary, and educational purposes. Clinical investigations are supported by the research and development divisions of major pharmaceutical companies and the national heart, lung, and blood institute of the national institutes of health.

Not for profit, exclusively for scientific, literary, and educational purposes. Clinical investigations are supported by the research and development divisions of major pharmaceutical companies and national heart, lung, and blood institute of the national institutes for health.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$174,896--
Accounts Receivable$10,903--
Total Assets$185,799$0▼ $185,799
Liabilities
Other Liabilities$221,326$220,412▼ $914
Accounts Payable and Accrued Expenses$33,355$53,510▲ $20,155
Total Liabilities$254,681$273,922▲ $19,241
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$-68,882$-273,922▼ $205,040
Total Net Assets Fund Balance$-68,882$-273,922▼ $205,040
Total Liabilities and Net Assets / Fund Balance$185,799$0▼ $185,799
Compensation and Service Providers

Board Members and Trustees

NameTitle
Leonard AltmanTrustee
Tatum AshleyTrustee
Virant FrankTrustee
Winterroth Lisa CTrustee
Revenue and Support

Revenue Composition

Contributions and Grants
$17,955
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$17,955
Change in Net Assets
$-48,481
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$60,513
Salaries, Compensation, and Employee Benefits$5,923
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$30,635$1,678-$32,313
Fees for Services Legal-$20,000-$20,000
Fees for Services Accounting-$8,200-$8,200
Other Salaries and Wages-$5,923-$5,923
Total Functional Expenses$30,635$35,801$0$66,436
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Naac Loans$220,412
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI

All board members of asthma inc are current or former owners of northwest asthma and allergy center, a related for profit company.

Form 990, Page 6, Part VI, Line 11B

Each trustee will receive a copy of the form 990 for review before filing of return.

Form 990, Page 6, Part VI, Line 15A

Compensation for top officials is established and periodically reviewed by the trustees who manage activity. Compensation is approved through a budgeting process annually

Form 990, Page 6, Part VI, Line 19

Asthma inc will make its governing documents vailable to the public upon written request.

Filing and Contact Details

Filer

Filer Name
Associated Scientists to Help
EIN
23-7219813
Phone
2065255520
Address
9725 3RD AVENUE NE, SEATTLE, WA 98115-2024
Doing Business As
Asthma

Signing Officer

Name
Winterroth Lisa C
Title
Trustee
Phone
2065255520
Signed
2026-01-08
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Winterroth Lisa C
Formed
1972
Legal Domicile
Wa
Voting Board Members
0
Independent Board Members
0
Employees
0

Preparer

Firm
Wallace & Associates Ps
Address
4205 148TH AVENUE NE SUITE 200, BELLEVUE, WA 98007
Preparer
Marc Wallace CPA
Phone
4254534806
Supplemental Narrative

Additional Explanations

Form 990, Page 2, Part III, Line 4D

Research was performed with clinical investigations for the development divisions of major pharmaceutical companies.

Form 990, Part IX, Line 11G

Payroll services 3,687 0 0 outside services 2,065 0 0 fellowship expenses 8,300 0 0 taxes 470 0 0 bank fees 0 1,678 0 administrative costs 120 0 0 license 260 0 0 repairs & maintenance 14,761 0 0 study direct expenses 972 0 0 total 30,635 1,678 0

Form 990, Part XI, Line 9

Transfer of charitable assets to 0 virginia mason foundation -122,860 transfer cash to trustee -33,699 total -156,559

Raw XML Appendix282 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt033355
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt053510
IRS990/AccountsReceivableGrp/BOYAmt010903
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0NOT FOR PROFIT, EXCLUSIVELY FOR SCIENTIFIC, LITERARY, AND EDUCATIONAL PURPOSES. CLINICAL INVESTIGATIONS ARE SUPPORTED BY THE RESEARCH AND DEVELOPMENT DIVISIONS OF MAJOR PHARMACEUTICAL COMPANIES AND NATIONAL HEART, LUNG, AND BLOOD INSTITUTE OF THE NATIONAL INSTITUTES FOR HEALTH.
IRS990/AllOtherContributionsAmt017955
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BooksInCareOfDetail/PersonNm0SIMON SIU
IRS990/BooksInCareOfDetail/PhoneNum02065267724
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt09725 3RD AVE NE SUITE 500
IRS990/BooksInCareOfDetail/USAddress/CityNm0SEATTLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0WA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd098115
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0174896
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContractTerminationInd0X
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt017955
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt060513
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-48481
IRS990/CYSalariesCompEmpBnftPaidAmt05923
IRS990/CYTotalExpensesAmt066436
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt017955
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0ASTHMA INC CONDUCTS RESEARCH STUDIES FOR COMPANIES THAT WANT TO TEST EXPERIMENTAL MEDICATIONS, DEVICES OR TREATMENTS.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DoingBusinessAsName/BusinessNameLine1Txt0ASTHMA
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt08200
IRS990/FeesForServicesAccountingGrp/TotalAmt08200
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt020000
IRS990/FeesForServicesLegalGrp/TotalAmt020000
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt01678
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt030635
IRS990/FeesForServicesOtherGrp/TotalAmt032313
IRS990/FinalReturnInd0X
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/PersonNm0WINTERROTH LISA C
IRS990/Form990PartVIISectionAGrp/PersonNm1TATUM ASHLEY
IRS990/Form990PartVIISectionAGrp/PersonNm2VIRANT FRANK
IRS990/Form990PartVIISectionAGrp/PersonNm3LEONARD ALTMAN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/TitleTxt0TRUSTEE
IRS990/Form990PartVIISectionAGrp/TitleTxt1TRUSTEE
IRS990/Form990PartVIISectionAGrp/TitleTxt2TRUSTEE
IRS990/Form990PartVIISectionAGrp/TitleTxt3TRUSTEE
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/FormationYr01972
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt00
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt017955
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0WA
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0TO INVESTIGATE NEW TREATMENTS IN ALLERGY, ASTHMA, AND IMMUNOLOGY.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0-68882
IRS990/NetAssetsOrFundBalancesEOYAmt0-273922
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0-68882
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0-273922
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-156559
IRS990/OtherLiabilitiesGrp/BOYAmt0221326
IRS990/OtherLiabilitiesGrp/EOYAmt0220412
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt05923
IRS990/OtherSalariesAndWagesGrp/TotalAmt05923
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0WINTERROTH LISA C
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgSrvcAccomActyOtherGrp/Desc0RESEARCH WAS PERFORMED WITH CLINICAL INVESTIGATIONS FOR THE DEVELOPMENT DIVISIONS OF MAJOR PHARMACEUTICAL COMPANIES.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt030635
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt072140
IRS990/PYExcessBenefitTransInd0false
IRS990/PYOtherExpensesAmt0215004
IRS990/PYProgramServiceRevenueAmt0141385
IRS990/PYRevenuesLessExpensesAmt0-171809
IRS990/PYSalariesCompEmpBnftPaidAmt0170330
IRS990/PYTotalExpensesAmt0385334
IRS990/PYTotalRevenueAmt0213525
IRS990/ReconcilationRevenueExpnssAmt0-48481
IRS990/RegularMonitoringEnfrcInd0false
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0SEATTLE
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0WA
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0SEATTLE CHILDRENS HOSPITAL
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine2Txt0UNIVERSITY OF WASHINGTON MEDICAL CENTER
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0220412
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0NAAC LOANS
IRS990ScheduleD/TotalLiabilityAmt0220412
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleN/AssetsDistributedInd0true
IRS990ScheduleN/BondsOutstandingInd0false
IRS990ScheduleN/DirectorOfSuccessorInd0false
IRS990ScheduleN/EmployeeOfSuccessorInd0false
IRS990ScheduleN/LiabilitiesPaidInd0false
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc0CASH
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt02025-02-24
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN0910565539
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt0122860
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt0501(C)(3)
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt0CASH
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/PersonNm0VIRGINIA MASON FOUNDATION
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt01100 9TH AVE
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm0SEATTLE
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd0WA
IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd098101
IRS990ScheduleN/OwnerOfSuccessorInd0false
IRS990ScheduleN/ReceiveCompensationInd0false
IRS990ScheduleN/RequiredToNotifyAGInd0true
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0RESEARCH WAS PERFORMED WITH CLINICAL INVESTIGATIONS FOR THE DEVELOPMENT DIVISIONS OF MAJOR PHARMACEUTICAL COMPANIES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALL BOARD MEMBERS OF ASTHMA INC ARE CURRENT OR FORMER OWNERS OF NORTHWEST ASTHMA AND ALLERGY CENTER, A RELATED FOR PROFIT COMPANY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2EACH TRUSTEE WILL RECEIVE A COPY OF THE FORM 990 FOR REVIEW BEFORE FILING OF RETURN.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3COMPENSATION FOR TOP OFFICIALS IS ESTABLISHED AND PERIODICALLY REVIEWED BY THE TRUSTEES WHO MANAGE ACTIVITY. COMPENSATION IS APPROVED THROUGH A BUDGETING PROCESS ANNUALLY
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4ASTHMA INC WILL MAKE ITS GOVERNING DOCUMENTS VAILABLE TO THE PUBLIC UPON WRITTEN REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5PAYROLL SERVICES 3,687 0 0 OUTSIDE SERVICES 2,065 0 0 FELLOWSHIP EXPENSES 8,300 0 0 TAXES 470 0 0 BANK FEES 0 1,678 0 ADMINISTRATIVE COSTS 120 0 0 LICENSE 260 0 0 REPAIRS & MAINTENANCE 14,761 0 0 STUDY DIRECT EXPENSES 972 0 0 TOTAL 30,635 1,678 0
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6TRANSFER OF CHARITABLE ASSETS TO 0 VIRGINIA MASON FOUNDATION -122,860 TRANSFER CASH TO TRUSTEE -33,699 TOTAL -156,559
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 2, PART III, LINE 4D
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 15A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART IX, LINE 11G
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0true
IRS990/TotalAssetsBOYAmt0185799
IRS990/TotalAssetsEOYAmt00
IRS990/TotalAssetsGrp/BOYAmt0185799
IRS990/TotalAssetsGrp/EOYAmt00
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt017955
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt035801
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt030635
IRS990/TotalFunctionalExpensesGrp/TotalAmt066436
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0254681
IRS990/TotalLiabilitiesEOYAmt0273922
IRS990/TotalLiabilitiesGrp/BOYAmt0254681
IRS990/TotalLiabilitiesGrp/EOYAmt0273922
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0-68882
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0-273922
IRS990/TotalOtherProgSrvcExpenseAmt030635
IRS990/TotalProgramServiceExpensesAmt030635
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt017955
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0185799
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt09725 3RD AVE NE SUITE 500
IRS990/USAddress/CityNm0SEATTLE
IRS990/USAddress/StateAbbreviationCd0WA
IRS990/USAddress/ZIPCd0981152024
IRS990/VotingMembersGoverningBodyCnt00
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0WWW.ASTHMAINC.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0WINTERROTH LISA C
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TRUSTEE
ReturnHeader/BusinessOfficerGrp/PhoneNum02065255520
ReturnHeader/BusinessOfficerGrp/SignatureDt02026-01-08
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0ASSOCIATED SCIENTISTS TO HELP
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0MINIMIZE ALLERGIES
ReturnHeader/Filer/BusinessNameControlTxt0ASSO
ReturnHeader/Filer/EIN0237219813
ReturnHeader/Filer/PhoneNum02065255520
ReturnHeader/Filer/USAddress/AddressLine1Txt09725 3RD AVENUE NE
ReturnHeader/Filer/USAddress/CityNm0SEATTLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0WA
ReturnHeader/Filer/USAddress/ZIPCd0981152024
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0911745422
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0WALLACE & ASSOCIATES PS
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt04205 148TH AVENUE NE SUITE 200
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0BELLEVUE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0WA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd098007
ReturnHeader/PreparerPersonGrp/PhoneNum04254534806
ReturnHeader/PreparerPersonGrp/PreparationDt02026-01-26
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MARC WALLACE CPA
ReturnHeader/ReturnTs02026-02-04T18:48:37-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02025-01-01
ReturnHeader/TaxPeriodEndDt02025-06-30
ReturnHeader/TaxYr02025

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • <$500k nonprofits